S Chand & Company Ltd (SCHAND): Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 26, 2025, 11:16 am

Competitors of S Chand & Company Ltd (SCHAND)

All Competitor Stocks of S Chand & Company Ltd (SCHAND)

Quarterly Result

Last Updated: May 31, 2025, 7:55 am

Below is a detailed analysis of the quarterly data for S Chand & Company Ltd (SCHAND) based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 471.00 Cr.. The value appears strong and on an upward trend. It has increased from 100.00 Cr. (Dec 2024) to 471.00 Cr., marking an increase of 371.00 Cr..
• For Expenses, as of Mar 2025, the value is 268.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 119.00 Cr. (Dec 2024) to 268.00 Cr., marking an increase of 149.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 203.00 Cr.. The value appears strong and on an upward trend. It has increased from -19.00 Cr. (Dec 2024) to 203.00 Cr., marking an increase of 222.00 Cr..
• For OPM %, as of Mar 2025, the value is 43.00%. The value appears strong and on an upward trend. It has increased from -19.00% (Dec 2024) to 43.00%, marking an increase of 62.00%.
• For Other Income, as of Mar 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Dec 2024) to 6.00 Cr., marking an increase of 4.00 Cr..
• For Interest, as of Mar 2025, the value is 5.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.00 Cr. (Dec 2024) to 5.00 Cr., marking an increase of 2.00 Cr..
• For Depreciation, as of Mar 2025, the value is 12.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10.00 Cr. (Dec 2024) to 12.00 Cr., marking an increase of 2.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 193.00 Cr.. The value appears strong and on an upward trend. It has increased from -31.00 Cr. (Dec 2024) to 193.00 Cr., marking an increase of 224.00 Cr..
• For Tax %, as of Mar 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from -18.00% (Dec 2024) to 27.00%, marking an increase of 45.00%.
• For Net Profit, as of Mar 2025, the value is 142.00 Cr.. The value appears strong and on an upward trend. It has increased from -26.00 Cr. (Dec 2024) to 142.00 Cr., marking an increase of 168.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 40.26. The value appears strong and on an upward trend. It has increased from -6.99 (Dec 2024) to 40.26, marking an increase of 47.25.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:16 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:26 am

Below is a detailed analysis of the balance sheet data for S Chand & Company Ltd (SCHAND) based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 18.00 Cr..
• For Reserves, as of Mar 2025, the value is 973.00 Cr.. The value appears strong and on an upward trend. It has increased from 923.00 Cr. (Mar 2024) to 973.00 Cr., marking an increase of 50.00 Cr..
• For Borrowings, as of Mar 2025, the value is 108.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 133.00 Cr. (Mar 2024) to 108.00 Cr., marking a decrease of 25.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 167.00 Cr.. The value appears to be improving (decreasing). It has decreased from 199.00 Cr. (Mar 2024) to 167.00 Cr., marking a decrease of 32.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,266.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,273.00 Cr. (Mar 2024) to 1,266.00 Cr., marking a decrease of 7.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 532.00 Cr.. The value appears strong and on an upward trend. It has increased from 524.00 Cr. (Mar 2024) to 532.00 Cr., marking an increase of 8.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 79.00 Cr.. The value appears strong and on an upward trend. It has increased from 62.00 Cr. (Mar 2024) to 79.00 Cr., marking an increase of 17.00 Cr..
• For Other Assets, as of Mar 2025, the value is 654.00 Cr.. The value appears to be declining and may need further review. It has decreased from 687.00 Cr. (Mar 2024) to 654.00 Cr., marking a decrease of 33.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,266.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,273.00 Cr. (Mar 2024) to 1,266.00 Cr., marking a decrease of 7.00 Cr..

Notably, the Reserves (973.00 Cr.) exceed the Borrowings (108.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for S Chand & Company Ltd (SCHAND), here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 18.04. This value is within the healthy range. It has increased from 14.53 (Mar 24) to 18.04, marking an increase of 3.51.
• For Diluted EPS (Rs.), as of Mar 25, the value is 18.03. This value is within the healthy range. It has increased from 14.53 (Mar 24) to 18.03, marking an increase of 3.50.
• For Cash EPS (Rs.), as of Mar 25, the value is 29.09. This value is within the healthy range. It has increased from 27.64 (Mar 24) to 29.09, marking an increase of 1.45.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 280.93. It has increased from 268.02 (Mar 24) to 280.93, marking an increase of 12.91.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 280.93. It has increased from 268.02 (Mar 24) to 280.93, marking an increase of 12.91.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 204.16. It has increased from 188.14 (Mar 24) to 204.16, marking an increase of 16.02.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 42.00. This value is within the healthy range. It has increased from 33.99 (Mar 24) to 42.00, marking an increase of 8.01.
• For PBIT / Share (Rs.), as of Mar 25, the value is 30.00. This value is within the healthy range. It has increased from 20.87 (Mar 24) to 30.00, marking an increase of 9.13.
• For PBT / Share (Rs.), as of Mar 25, the value is 26.34. This value is within the healthy range. It has increased from 16.54 (Mar 24) to 26.34, marking an increase of 9.80.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 17.09. This value is within the healthy range. It has increased from 14.52 (Mar 24) to 17.09, marking an increase of 2.57.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 18.02. This value is within the healthy range. It has increased from 16.08 (Mar 24) to 18.02, marking an increase of 1.94.
• For PBDIT Margin (%), as of Mar 25, the value is 20.57. This value is within the healthy range. It has increased from 18.06 (Mar 24) to 20.57, marking an increase of 2.51.
• For PBIT Margin (%), as of Mar 25, the value is 14.69. This value is within the healthy range. It has increased from 11.09 (Mar 24) to 14.69, marking an increase of 3.60.
• For PBT Margin (%), as of Mar 25, the value is 12.90. This value is within the healthy range. It has increased from 8.79 (Mar 24) to 12.90, marking an increase of 4.11.
• For Net Profit Margin (%), as of Mar 25, the value is 8.36. This value is within the healthy range. It has increased from 7.71 (Mar 24) to 8.36, marking an increase of 0.65.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.82. This value is within the healthy range. It has increased from 8.54 (Mar 24) to 8.82, marking an increase of 0.28.
• For Return on Networth / Equity (%), as of Mar 25, the value is 6.41. This value is below the healthy minimum of 15. It has increased from 6.01 (Mar 24) to 6.41, marking an increase of 0.40.
• For Return on Capital Employeed (%), as of Mar 25, the value is 10.07. This value is within the healthy range. It has increased from 7.39 (Mar 24) to 10.07, marking an increase of 2.68.
• For Return On Assets (%), as of Mar 25, the value is 5.02. This value is within the healthy range. It has increased from 4.44 (Mar 24) to 5.02, marking an increase of 0.58.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.06. This value is within the healthy range. It has decreased from 0.11 (Mar 24) to 0.06, marking a decrease of 0.05.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.56. It has increased from 0.53 (Mar 24) to 0.56, marking an increase of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 2.77. This value is within the healthy range. It has increased from 2.22 (Mar 24) to 2.77, marking an increase of 0.55.
• For Quick Ratio (X), as of Mar 25, the value is 2.12. This value exceeds the healthy maximum of 2. It has increased from 1.59 (Mar 24) to 2.12, marking an increase of 0.53.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 4. It has increased from 1.31 (Mar 24) to 1.42, marking an increase of 0.11.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 18.65 (Mar 24) to 0.00, marking a decrease of 18.65.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 10.27 (Mar 24) to 0.00, marking a decrease of 10.27.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 81.35 (Mar 24) to 0.00, marking a decrease of 81.35.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 89.73 (Mar 24) to 0.00, marking a decrease of 89.73.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 11.48. This value is within the healthy range. It has increased from 7.84 (Mar 24) to 11.48, marking an increase of 3.64.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.67. This value is within the healthy range. It has increased from 4.35 (Mar 24) to 5.67, marking an increase of 1.32.
• For Enterprise Value (Cr.), as of Mar 25, the value is 545.79. It has decreased from 804.96 (Mar 24) to 545.79, marking a decrease of 259.17.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 1. It has decreased from 1.21 (Mar 24) to 0.75, marking a decrease of 0.46.
• For EV / EBITDA (X), as of Mar 25, the value is 3.69. This value is below the healthy minimum of 5. It has decreased from 6.72 (Mar 24) to 3.69, marking a decrease of 3.03.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has decreased from 1.24 (Mar 24) to 0.82, marking a decrease of 0.42.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 81.34 (Mar 24) to 0.00, marking a decrease of 81.34.
• For Price / BV (X), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 1. It has decreased from 0.87 (Mar 24) to 0.60, marking a decrease of 0.27.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has decreased from 1.24 (Mar 24) to 0.82, marking a decrease of 0.42.
• For EarningsYield, as of Mar 25, the value is 0.10. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.10, marking an increase of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness